Baxter International BAX Pharmaceuticals — Selling, general and administrative expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's pharmaceuticals — selling, general and administrative expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's pharmaceuticals — selling, general and administrative expenses?
- Baxter International (BAX) reported pharmaceuticals — selling, general and administrative expenses of $102M in Q1 2026.
- How has Baxter International's pharmaceuticals — selling, general and administrative expenses changed year-over-year?
- Baxter International's pharmaceuticals — selling, general and administrative expenses decreased by 1.0% year-over-year, from $103M to $102M.
- What is the long-term trend for Baxter International's pharmaceuticals — selling, general and administrative expenses?
- Over 3 years (2022 to 2025), Baxter International's pharmaceuticals — selling, general and administrative expenses has grown at a 5.9% compound annual growth rate (CAGR), from $361M to $429M.
- What does pharmaceuticals — selling, general and administrative expenses mean?
- The overhead and operating costs required to manage and sell products within the Pharmaceuticals segment.
- How do you interpret pharmaceuticals — selling, general and administrative expenses?
- Lower expenses relative to revenue suggest better operational leverage, whereas rising costs may indicate increased investment in growth or inefficiencies.
- How does pharmaceuticals — selling, general and administrative expenses compare across companies?
- Commonly compared across peers to assess the cost-to-serve ratio in pharmaceutical distribution.